ADENOCARCINOMA
Clinical trials for ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in tough pancreatic cancer
Disease control OngoingThis early-phase study tests whether combining pembrolizumab and lenvatinib can help control advanced pancreatic cancer that has not responded to prior treatment. Fifteen adults with metastatic pancreatic ductal adenocarcinoma will receive the drug combination. The goal is to see…
Matched conditions: ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:11 UTC
-
Radioactive antibody takes aim at Hard-to-Treat prostate cancer
Disease control OngoingThis early-phase study tests a new drug called JNJ-69086420 for men with advanced prostate cancer that has spread and is no longer responding to hormone therapy. The drug is an antibody linked to a radioactive particle that targets a protein found on prostate cancer cells. The st…
Matched conditions: ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Mini GPS in a needle could make cancer biopsies more precise
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a special needle with a tiny tracking device inside, like a mini GPS, to help doctors find hard-to-see tumors during biopsies or ablation procedures. About 3,900 adults with certain cancers or growths will take part. The goal is to see if this tool can place the …
Matched conditions: ADENOCARCINOMA
Phase: NA • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
15-Year checkup: what happens after experimental cancer therapy?
Knowledge-focused ENROLLING_BY_INVITATIONThis study does not provide new treatment. Instead, it follows up to 1,150 people who previously received experimental cell or gene therapies for cancers like melanoma and neuroendocrine tumors. Participants will have yearly physical exams and blood tests for up to 15 years to mo…
Matched conditions: ADENOCARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC